EORTCMYC is a highly desirable oncogenic target that historically eluded drug huntersSmall molecules that inhibit the oncogenic function of MYC were discovered using Dewpoint’s AI/ML and condensate ...
Arima Genomics announces a new study showing that the Aventa™ lymphoma test resolves diagnostic ambiguity and guides care in ...
Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or ...
A research team has outlined how synthetic biology can accelerate discoveries in plant–microbe interactions, offering ...
To qualify for Medicare Part C (Medicare Advantage), you must enroll in Medicare Parts A and B and live in the desired Part C plan’s service area. Medicare Part C, also called Medicare Advantage, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback